Article
An integrated Drosophila model system reveals unique properties for F14512, a novel polyamine-containing anticancer drug that targets topoisomerase II.
PloS one - 1 Jan 2011
Chelouah Sonia, Monod-Wissler Caroline, Bailly Christian, Barret Jean-Marc, Guilbaud Nicolas, Vispé Stéphane, Käs Emmanuel
Abstract excerpt
F14512 is a novel anti-tumor molecule based on an epipodophyllotoxin core coupled to a cancer-cell vectoring spermine moiety. This polyamine linkage is assumed to ensure the preferential uptake of F14512 by cancer cells, strong interaction with DNA and potent inhibition of topoisomerase II (Topo II). The antitumor activity of F14512 in human tumor models is significantly higher than that of other...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
